Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)Tryfon Zarganes‐Tzitzikas, Alexander Dömlingꝉ, Dobrosława Krzemień et al.|Expert Opinion on Therapeutic Patents|2016Cited by 104